Cc. Pilbeam et al., DIFFERENTIAL-EFFECTS OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS ON CONSTITUTIVE AND INDUCIBLE PROSTAGLANDIN G H SYNTHASE IN CULTURED BONE-CELLS/, Journal of bone and mineral research, 12(8), 1997, pp. 1198-1203
The production of prostaglandins by osteoblasts is an important mechan
ism for the regulation of bone turnover, Bone cells contain both induc
ible and constitutive prostaglandin G/H synthase (PGHS-2 and PGHS-1) a
nd these are differentially regulated, Nonsteroidal anti-inflammatory
drugs (NSAIDs), which selectively inhibit one of these enzymes, would
be useful in assessing their relative roles in bone metabolism, By Nor
thern analysis, only PGHS-2 is expressed by the immortalized rat osteo
blastic cell line, Py1a, while only PGHS-1 is expressed by the rat ost
eosarcoma cell line, ROS 17/2.8. We tested the relative inhibitory pot
ency (IC50) of seven different NSAIDs on these two cell lines, A recen
tly described selective inhibitor of PGHS-2 NS-398, was approximately
30 times more potent in inhibiting PGHS-2 than PGHS-1, and diclofenac
was approximately 10 times more potent, Both had IC50's of approximate
ly 3 nM for PGHS-2 in Py1a cells, Indomethacin, flurbiprofen, naproxen
, and piroxicam were relatively nonselective,vith IC50's ranging from
30 nM to 1 mu M, while 6-methoxy-2 naphthyl acetic acid, the active me
tabolite of nabumetone, was inhibitory only at concentrations greater
than 1 mu M. These results indicate that the presently available NSAID
s are unlikely to distinguish completely between effects mediated by P
GHS-2 or PGHS-1. However, the cell systems employed could provide a mo
del for the analysis of new compounds with greater selective activity.